{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:53:39Z","timestamp":1794513219389,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prevention of dementia is a public health priority, and the identification of potential biomarkers may provide benefits for early detection and prevention. This study investigates the association of common serum laboratory tests with the risk of incident dementia. Among 407,190 participants from the UK Biobank (median follow-up of 9.19 years), we investigated the linear and nonlinear effects of 30 laboratory measures on the risk of all-cause dementia using Cox models and restricted cubic spline models. We found that dementia incidence was associated with low vitamin D concentration (hazard ratio 0.994, 95% confidence interval 0.993\u20130.996), indicators of endocrine disorders: IGF-1 level (<jats:italic>P<\/jats:italic>for non-linearity\u2009=\u20091.1E-05), testosterone level (<jats:italic>P<\/jats:italic>for non-linearity\u2009=\u20090.006); high sex-hormone-binding globulin level (HR 1.004, 95% CI: 1.003\u20131.006); reduced liver function: lower alanine aminotransferase (HR 0.990, 95% CI: 0.986\u20130.995); renal dysfunction: cystatin C level (<jats:italic>P<\/jats:italic>for non-linearity\u2009=\u20090.028); oxidative stress: lower urate level (HR 0.998, 95% CI: 0.998\u20130.999); lipids dysregulation: lower LDL (HR 0.918, 95% CI: 0.872\u20130.965) and triglycerides (HR 0.924, 95% CI: 0.882\u20130.967) concentrations; insulin resistance: high glucose (HR 1.093, 95% CI: 1.045\u20131.143) and HbA1c (HR 1.017, 95% CI: 1.009\u20131.025) levels; immune dysbiosis: C\u2212reactive protein (<jats:italic>P<\/jats:italic>for non-linearity\u2009=\u20095.5E-09). In conclusion, markers of vitamin D deficiency, GH-IGF-1 axis disorders, bioactive sex hormone deficiency, reduced liver function, renal abnormalities, oxidation, insulin resistance, immune dysbiosis, and lipids dysregulation were associated with incident dementia. Our results support a contributory role of systemic disorders and diverse biological processes to onset of dementia.<\/jats:p>","DOI":"10.1038\/s41398-022-02082-x","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:02:37Z","timestamp":1659589357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals"],"prefix":"10.1038","volume":"12","author":[{"given":"Xiao-Yu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-383X","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"2082_CR1","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673\u2013734.","journal-title":"Lancet"},{"key":"2082_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u201346.","journal-title":"Lancet"},{"key":"2082_CR3","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s12035-018-1151-4","volume":"56","author":"TT Htike","year":"2019","unstructured":"Htike TT, Mishra S, Kumar S, Padmanabhan P, Guly\u00e1s B. Peripheral biomarkers for early detection of alzheimer\u2019s and parkinson\u2019s diseases. Mol Neurobiol. 2019;56:2256\u201377.","journal-title":"Mol Neurobiol"},{"key":"2082_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","volume":"18","author":"MR Irwin","year":"2019","unstructured":"Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation for Alzheimer\u2019s disease dementia. Lancet Neurol. 2019;18:296\u2013306.","journal-title":"Lancet Neurol"},{"key":"2082_CR5","doi-asserted-by":"crossref","unstructured":"Sheppard O, Coleman M. Alzheimer\u2019s disease: etiology, neuropathology and pathogenesis. In: Huang X, editor. Alzheimer\u2019s Disease: Drug Discovery. Brisbane (AU): Exon Publications; 2020.","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch1"},{"key":"2082_CR6","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","volume":"64","author":"MM Mielke","year":"2005","unstructured":"Mielke MM, Zandi PP, Sj\u00f6gren M, Gustafson D, Ostling S, Steen B, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689\u201395.","journal-title":"Neurology"},{"key":"2082_CR7","doi-asserted-by":"publisher","first-page":"e1002265","DOI":"10.1371\/journal.pmed.1002265","volume":"14","author":"S Schilling","year":"2017","unstructured":"Schilling S, Tzourio C, Soumar\u00e9 A, Kaffashian S, Dartigues JF, Ancelin ML, et al. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. PLoS Med. 2017;14:e1002265.","journal-title":"PLoS Med"},{"key":"2082_CR8","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3233\/JAD-201241","volume":"79","author":"Y Lu","year":"2021","unstructured":"Lu Y, Pike JR, Selvin E, Mosley T, Palta P, Sharrett AR, et al. Low liver enzymes and risk of dementia: the atherosclerosis risk in communities (ARIC) study. J Alzheimers Dis. 2021;79:1775\u201384.","journal-title":"J Alzheimers Dis"},{"key":"2082_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jalz.2016.03.003","volume":"12","author":"SK Kunutsor","year":"2016","unstructured":"Kunutsor SK, Laukkanen JA. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study. Alzheimers Dement. 2016;12:931\u201341.","journal-title":"Alzheimers Dement"},{"key":"2082_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3233\/JAD-142262","volume":"44","author":"TK Khan","year":"2015","unstructured":"Khan TK, Alkon DL. Peripheral biomarkers of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;44:729\u201344.","journal-title":"J Alzheimers Dis"},{"key":"2082_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01505-5","volume":"11","author":"M Wainberg","year":"2021","unstructured":"Wainberg M, Kloiber S, Diniz B, McIntyre RS, Felsky D, Tripathy SJ. Clinical laboratory tests and five-year incidence of major depressive disorder: a prospective cohort study of 433,890 participants from the UK Biobank. Transl Psychiatry. 2021;11:380.","journal-title":"Transl Psychiatry"},{"key":"2082_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186:1026\u201334.","journal-title":"Am J Epidemiol"},{"key":"2082_CR13","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"2082_CR14","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","volume":"55","author":"M Xue","year":"2019","unstructured":"Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944.","journal-title":"Ageing Res Rev"},{"key":"2082_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jgs.15733","volume":"67","author":"YB Lv","year":"2019","unstructured":"Lv YB, Mao C, Gao X, Yin ZX, Kraus VB, Yuan JQ, et al. Triglycerides paradox among the oldest old: \u201cthe lower the better?\u201d. J Am Geriatr Soc. 2019;67:741\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"2082_CR16","doi-asserted-by":"publisher","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","volume":"2","author":"K Nho","year":"2019","unstructured":"Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, et al. Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open. 2019;2:e197978.","journal-title":"JAMA Netw Open"},{"key":"2082_CR17","doi-asserted-by":"publisher","first-page":"6097820","DOI":"10.1155\/2020\/6097820","volume":"2020","author":"S Sultan","year":"2020","unstructured":"Sultan S, Taimuri U, Basnan SA, Ai-Orabi WK, Awadallah A, Almowald F, et al. Low vitamin D and its association with cognitive impairment and dementia. J Aging Res. 2020;2020:6097820.","journal-title":"J Aging Res"},{"key":"2082_CR18","first-page":"43","volume":"3","author":"TJ Littlejohns","year":"2016","unstructured":"Littlejohns TJ, Kos K, Henley WE, Ku\u017ama E, Llewellyn DJ. Vitamin D and dementia. J Prev Alzheimers Dis. 2016;3:43\u201352.","journal-title":"J Prev Alzheimers Dis"},{"key":"2082_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000339702","volume":"33","author":"T Etgen","year":"2012","unstructured":"Etgen T, Sander D, Bickel H, Sander K, F\u00f6rstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord. 2012;33:297\u2013305.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2082_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/tam.6.1.13.17","volume":"6","author":"RS Tan","year":"2003","unstructured":"Tan RS, Pu SJ. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer\u2019s disease. Aging Male. 2003;6:13\u201317.","journal-title":"Aging Male"},{"key":"2082_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1871527315666151110125704","volume":"15","author":"EJ Wahjoepramono","year":"2016","unstructured":"Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, et al. The effects of testosterone supplementation on cognitive functioning in older men. CNS Neurol Disord Drug Targets. 2016;15:337\u201343.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2082_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.2174\/1871527314666150429112112","volume":"14","author":"PR Asih","year":"2015","unstructured":"Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, de Ruyck K, Taddei K, et al. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. CNS Neurol Disord Drug Targets. 2015;14:576\u201386.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2082_CR23","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.neurobiolaging.2008.10.001","volume":"31","author":"M Muller","year":"2010","unstructured":"Muller M, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Sex hormone binding globulin and incident Alzheimer\u2019s disease in elderly men and women. Neurobiol Aging. 2010;31:1758\u201365.","journal-title":"Neurobiol Aging"},{"key":"2082_CR24","doi-asserted-by":"publisher","first-page":"20350","DOI":"10.18632\/aging.103813","volume":"12","author":"YJ Ge","year":"2020","unstructured":"Ge YJ, Xu W, Tan CC, Tan L. Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis. Aging (Albany NY). 2020;12:20350\u201365.","journal-title":"Aging (Albany NY)"},{"key":"2082_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3233\/JAD-180302","volume":"66","author":"CN Winston","year":"2018","unstructured":"Winston CN, Goetzl EJ, Baker LD, Vitiello MV, Rissman RA. Growth hormone-releasing hormone modulation of neuronal exosome biomarkers in mild cognitive impairment. J Alzheimers Dis. 2018;66:971\u201381.","journal-title":"J Alzheimers Dis"},{"key":"2082_CR26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","volume":"82","author":"AJ Westwood","year":"2014","unstructured":"Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology. 2014;82:1613\u20139.","journal-title":"Neurology"},{"key":"2082_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.arr.2017.12.002","volume":"42","author":"J Frater","year":"2018","unstructured":"Frater J, Lie D, Bartlett P, McGrath JJ. Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review. Ageing Res Rev. 2018;42:14\u201327.","journal-title":"Ageing Res Rev"},{"key":"2082_CR28","doi-asserted-by":"crossref","first-page":"e13443","DOI":"10.1111\/acel.13443","volume":"20","author":"WB Zhang","year":"2021","unstructured":"Zhang WB, Ye K, Barzilai N, Milman S. The antagonistic pleiotropy of insulin-like growth factor 1. Aging Cell. 2021;20:e13443.","journal-title":"Aging Cell"},{"key":"2082_CR29","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","volume":"54","author":"YR Wang","year":"2017","unstructured":"Wang YR, Wang QH, Zhang T, Liu YH, Yao XQ, Zeng F, et al. Associations between hepatic functions and plasma amyloid-beta levels-implications for the capacity of liver in peripheral amyloid-beta clearance. Mol Neurobiol. 2017;54:2338\u201344.","journal-title":"Mol Neurobiol"},{"key":"2082_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-\u03b2 metabolism beyond the brain. Nat Rev Neurol. 2017;13:612\u201323.","journal-title":"Nat Rev Neurol"},{"key":"2082_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","volume":"74","author":"DA Drew","year":"2019","unstructured":"Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74:782\u201390.","journal-title":"Am J Kidney Dis"},{"key":"2082_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kint.2019.10.032","volume":"97","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, Okusa MD. Crosstalk between the nervous system and the kidney. Kidney Int. 2020;97:466\u201376.","journal-title":"Kidney Int"},{"key":"2082_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16:452\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"2082_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12035-014-8854-y","volume":"52","author":"YH Liu","year":"2015","unstructured":"Liu YH, Xiang Y, Wang YR, Jiao SS, Wang QH, Bu XL, et al. Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol Neurobiol. 2015;52:115\u20139.","journal-title":"Mol Neurobiol"},{"key":"2082_CR35","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DY Tian","year":"2021","unstructured":"Tian DY, Cheng Y, Zhuang ZQ, He CY, Pan QG, Tang MZ, et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:6074\u201382.","journal-title":"Mol Psychiatry"},{"key":"2082_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jalz.2019.01.014","volume":"15","author":"L Scheepers","year":"2019","unstructured":"Scheepers L, Jacobsson LTH, Kern S, Johansson L, Dehlin M, Skoog I. Urate and risk of Alzheimer\u2019s disease and vascular dementia: A population-based study. Alzheimers Dement. 2019;15:754\u201363.","journal-title":"Alzheimers Dement"},{"key":"2082_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/nu10080975","volume":"10","author":"C Tana","year":"2018","unstructured":"Tana C, Ticinesi A, Prati B, Nouvenne A, Meschi T. Uric Acid and Cognitive Function in Older Individuals. Nutrients. 2018;10:975.","journal-title":"Nutrients"},{"key":"2082_CR38","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1017\/S2045796019000374","volume":"29","author":"IK Wium-Andersen","year":"2019","unstructured":"Wium-Andersen IK, Rungby J, J\u00f8rgensen MB, Sandb\u00e6k A, Osler M, Wium-Andersen MK. Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose. Epidemiol Psychiatr Sci. 2019;29:e43.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2082_CR39","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.3233\/JAD-179911","volume":"64","author":"JR Clarke","year":"2018","unstructured":"Clarke JR, Ribeiro FC, Frozza RL, De Felice FG, Lourenco MV. Metabolic dysfunction in alzheimer\u2019s disease: from basic neurobiology to clinical approaches. J Alzheimers Dis. 2018;64:S405\u2013s426.","journal-title":"J Alzheimers Dis"},{"key":"2082_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","volume":"90","author":"XN Shen","year":"2019","unstructured":"Shen XN, Niu LD, Wang YJ, Cao XP, Liu Q, Tan L, et al. Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies. J Neurol Neurosurg Psychiatry. 2019;90:590\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2082_CR41","doi-asserted-by":"crossref","unstructured":"Hegazy SH, Thomassen JQ, Rasmussen IJ, Nordestgaard BG, Tybjaerg-Hansen A, Frikke-Schmidt R C-reactive protein levels and risk of dementia-Observational and genetic studies of 111,242 individuals from the general population. Alzheimers Dement. 2022. Online ahead of print.","DOI":"10.1002\/alz.12568"},{"key":"2082_CR42","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/jgs.12994","volume":"62","author":"MA Wichmann","year":"2014","unstructured":"Wichmann MA, Cruickshanks KJ, Carlsson CM, Chappell R, Fischer ME, Klein BE, et al. Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc. 2014;62:1683\u201391.","journal-title":"J Am Geriatr Soc"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02082-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T08:47:29Z","timestamp":1700902049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02082-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}